PLA2G4A and nervous system disorder: In our efforts to develop potential drug candidates to treat neurological disorders, we have synthesized a new class of AA analogues and identified one compound, 2i that is a non-cytotoxic, cPLA2-selective inhibitor which inhibits the enzyme more potently than AACOCF3.